The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Concurrent TP53 mutation adversely impact the efficacy of crizotinib in ROS1-rearranged lung cancer patients.
 
Lin Gen
No Relationships to Disclose
 
Huamin Xu
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Jinliang Kong
No Relationships to Disclose
 
Xinghao Ai
No Relationships to Disclose
 
Fenglei Yu
No Relationships to Disclose
 
Kaiqi Du
No Relationships to Disclose
 
Lingjun Zhu
No Relationships to Disclose
 
Lin Li
No Relationships to Disclose
 
Hongxia Ma
No Relationships to Disclose
 
Qiaoli Wang
No Relationships to Disclose
 
Huanhuan Xiong
No Relationships to Disclose
 
Rongrong Chen
No Relationships to Disclose
 
Xuefeng Xia
No Relationships to Disclose